The study found the mAbs induced tumor regression in immunocompetent wild type C57BL/6 mice specifically expressing the target protein (PRL3 or EGFP), as well as in MMTV-PyMT transgenic spontaneous breast cancer models specifically expressing the target intracellular mT. This evidence concerns the gene PTP4A3 and neoplasm.